---
title: " <span style='color:red;'>Causal Inference and Observational Data</span>"
subtitle: "_Approaches and Limitations _" 
format: 
  revealjs:
    slide-number: true
    transition: slide
    theme: simple
    footer: Target Trial Emulation
    reference-location: document
    scrollable: TRUE
editor: visual
---

```{r setup, include=FALSE}
knitr::opts_chunk$set(echo = FALSE, warning = FALSE, message = FALSE)
library(DiagrammeR)
```

# [Introduction]{style="color:navy;"}

## [What we want]{style="color:#FF6666;"}

```{r}
library(DiagrammeR)

grViz("
  digraph {
    rankdir=LR
    node [shape = plaintext, fontcolor=navy, fontname=\"Arial\"]
    edge [color=red, penwidth=0.5]
    A -> Y
  }
")
```
## [Causal Inference]{style="color:#FF6666;"}
| Name       | A   | Y   | Y<sub>A=0</sub> | Y<sub>A=1</sub> |
|------------|-----|-----|-----------------|-----------------|
| Rheia      | 0   | 0   | 0               | ?               |
| Kronos     | 0   | 1   | 1               | ?               |
| Demeter    | 0   | 0   | 0               | ?               |
| Hades      | 0   | 0   | 0               | ?               |
| Hestia     | 1   | 0   | ?               | 0               |
| Poseidon   | 1   | 0   | ?               | 0               |
| Hera       | 1   | 0   | ?               | 0               |
| Zeus       | 1   | 1   | ?               | 1               |
| Artemis    | 1   | 1   | ?               | 1               |
| Apollo     | 1   | 1   | ?               | 1               |
| Leto       | 0   | 0   | 0               | ?               |
| Ares       | 1   | 1   | ?               | 1               |
| Athena     | 1   | 1   | ?               | 1               |
| Hephaestus | 1   | 1   | ?               | 1               |
| Aphrodite  | 1   | 1   | ?               | 1               |
| Polyphemus | 0   | 0   | 0               | ?               |
| Persephone | 0   | 0   | 0               | ?               |
| Hermes     | 1   | 0   | ?               | 0               |
| Hebe       | 1   | 0   | ?               | 0               |
| Dionysus   | 1   | 0   | ?               | 0               |




## [Causal Inference]{style="color:#FF6666;"}

::: {style="display: flex; justify-content: space-between; align-items: flex-start; gap: 20px;"}
::: {style="width: 30%; font-size: 0.7em;"}
| Name       | A   | Y   | Y<sub>A=0</sub> | Y<sub>A=1</sub> |
|------------|-----|-----|-----------------|-----------------|
| Rheia      | 0   | 0   | 0               | **0**           |
| Kronos     | 0   | 1   | 1               | **0**           |
| Demeter    | 0   | 0   | 0               | **0**           |
| Hades      | 0   | 0   | 0               | **0**           |
| Hestia     | 1   | 0   | **0**           | 0               |
| Poseidon   | 1   | 0   | **1**           | 0               |
| Hera       | 1   | 0   | **1**           | 0               |
| Zeus       | 1   | 1   | **1**           | 1               |
| Artemis    | 1   | 1   | **1**           | 1               |
| Apollo     | 1   | 1   | **0**           | 1               |
| Leto       | 0   | 0   | 0               | **0**           |
| Ares       | 1   | 1   | **1**           | 1               |
| Athena     | 1   | 1   | **1**           | 1               |
| Hephaestus | 1   | 1   | **1**           | 1               |
| Aphrodite  | 1   | 1   | **1**           | 1               |
| Polyphemus | 0   | 0   | 0               | **0**           |
| Persephone | 0   | 0   | 0               | **0**           |
| Hermes     | 1   | 0   | **1**           | 0               |
| Hebe       | 1   | 0   | **1**           | 0               |
| Dionysus   | 1   | 0   | **1**           | 0               |
:::

::: {style="width: 50%; font-size: 0.7em;"}
-   관측 결과는 Association을 보이는가?

-   처치를 받은 그룹의 위험이 처치를 받지 않은 그룹보다 큼.

-   만약 Potential Outcomes를 모두 Table 처럼 알 수 있다고 가정한다면 (실제는 불가능), Table 결과는 Causation을 보이는가?

-   모든 대상자가 심장 이식을 받았을 시의 위험과 받지 않았을 시의 위험이 같음.

-   **Association**과 **Causation**의 결과가 다른 것은, 심장 이식을 받은 대상자들이 받지 않은 대상자들에 비하여 **더 상태가 좋지 않을 것으로 예상**할 수 있음.

-   결과적으로 Confounding 이 존재함
:::
:::

------------------------------------------------------------------------

## [Causal Inference]{style="color:#FF6666;"}

-   Exchangeability: $Y^a \perp A$\
-   치료군의 potential treatment effect (a=0 or 1) 는 비치료군의 potential treatment effect (a=0 or 1)와 같다. 결과적으로, Conditional Risk = Marginal Risk

$$ Pr[Y^a = 1 | A = 1] = Pr[Y^a = 1 | A = 0] = Pr[Y^a = 1], \text{ for all } a $$

## [Causal Inference]{style="color:#FF6666;"}

-   Conditional Exchangeability $$ Pr[Y^a = 1 | A = 1, L = l] = Pr[Y^a = 1 | A = 0, L = l] = Pr[Y^a = 1 | L = l], \text{ for all } a $$

## [Causal Inference: What we want]{style="color:#FF6666;"}

$$E[Y | A = 1] - E[Y | A = 0] $$

$$E[Y^{a=1} | A = 1] - E[Y^{a=0} | A = 0] $$

$$E[Y^{a=1}] - E[Y^{a=0}] : \text{Average causal effect!} $$

## [RCT]{style="color:#FF6666;"}

::: incremental
-   Ideal **BUT** not always
-   *Ethical*
-   *Feasible*
-   *Timely*
:::

## [RCT: Ethics]{style="color:#FF6666;"}

::: incremental
-   Absence of clinical equipose
-   SUPPORT trial controversy <img src="img/support.png"/>
:::

## [RCT: Feasibility]{style="color:#FF6666;"}

-   Median age at NSCLC diagnosis: 73.5yrs
-   RCT: half under 60
-   Rare disease?

## [RCT: Feasibility]{style="color:#FF6666;"}

::: {.layout-ncol="2"}
<img src="img/nsclc.png"/> <img src="img/median.png"/>
:::

## [RCT: Time]{style="color:#FF6666;"}

::: {.column width="100%"}
<img src="img/aa.png" style="display: block; margin: auto; width: 80%; margin-top: 10px;"/> <br> - *Later confirmed by randomized trial*
:::

## [Real World Data]{style="color:#FF6666;"}

-   Need for observational Studies...
-   ***BUT***

## [RWD: Confounding]{style="color:#FF6666;"}

<img src="img/conf.png"/>

## [RWD: Time zero problem]{style="color:#FF6666;"}

-   Eligibility is met(E)
-   Time to start follow up(T0)
-   Assignment (A)

## [RWD: Time zero problem]{style="color:#FF6666;"}

::: incremental
-   Example
-   E: Lung cancer Dx
-   T: Start of Follow-up
-   A: Surgery(Control) assignment
:::

## [RWD: Time zero problem]{style="color:#FF6666;"}

::: {.column width="100%"}
-   **RCT**

```{r, echo=FALSE}
library(ggplot2)
library(grid)

p <- ggplot() + 
  geom_segment(aes(x = 0, y = 0.5, xend = 2.5, yend = 0.5), size = 1, color = "black") +
  geom_rect(aes(xmin = 2.5, xmax = 3.5, ymin = 0.45, ymax = 0.55), color = "black", fill = 'gray', alpha = 0.5) +
  annotate("text", x = 3, y = 0.60, label = "Washout period w/o\nstudy drug use", size = 3, hjust = 0.5) +
  geom_point(aes(x = 3.5, y = 0.5), shape = 15, size = 3, color = "red") +
  annotate("text", x = 3.5, y = 0.65, label = "A", color = "red", size = 5) +
  annotate("text", x = 3.5, y = 0.70, label = "T", color = "blue", size = 5) +
  annotate("text", x = 3.5, y = 0.75, label = "E", color = "black", size = 5) +
  geom_segment(aes(x = 3.5, y = 0.5, xend = 4.8, yend = 0.8), size = 1, color = "red") +  
  geom_segment(aes(x = 3.5, y = 0.5, xend = 4.8, yend = 0.2), size = 1, color = "red") + 
  geom_segment(aes(x = 4.8, y = 0.8, xend = 11.8, yend = 0.8), size = 1, color = "red") +
  geom_segment(aes(x = 4.8, y = 0.2, xend = 11.8, yend = 0.2), size = 1, color = "red") +
  annotate("text", x = 4.9, y = 0.9, label = expression(A[1]), hjust = 0, size = 6, color = "black") +
  annotate("text", x = 4.9, y = 0.1, label = expression(A[2]), hjust = 0, size = 6, color = "black") +
  annotate("text", x = 0.9, y = 0.75, label = "Randomized trial", fontface = "bold", size = 5, color = 'purple') +
  theme_void()
p
```
:::

## [RWD: Time zero problem]{style="color:#FF6666;"}

::: columns
::: {.column width="40%"}
-   **Prevalent user bias**
-   E: Cancer
-   T0:Follow up
-   A: Statin assign
:::

::: {.column width="60%"}
```{r, echo=FALSE}
library(ggplot2)
library(grid)

p <- ggplot() + 
  geom_segment(aes(x = 0, y = 0.5, xend = 2.5, yend = 0.5), size = 1, color = "black") +
  geom_rect(aes(xmin = 2.5, xmax = 3.5, ymin = 0.45, ymax = 0.55), color = "black", fill = 'gray', alpha = 0.5) +
  annotate("text", x = 3, y = 0.60, label = "Washout period w/o\nstudy drug use", size = 3, hjust = 0.5) +
  geom_point(aes(x = 3.5, y = 0.5), shape = 15, size = 3, color = "red") +
  annotate("text", x = 3.5, y = 0.65, label = "A", color = "red", size = 5) +
  annotate("text", x = 4.9, y = 0.85, label = "T0", color = "blue", size = 6) +
  annotate("text", x = 3.5, y = 0.70, label = "E", color = "black", size = 5) +
  geom_segment(aes(x = 3.5, y = 0.5, xend = 4.8, yend = 0.8), size = 1, color = "red") +  
  geom_segment(aes(x = 3.5, y = 0.5, xend = 4.8, yend = 0.2), size = 1, color = "red") + 
  geom_segment(aes(x = 4.8, y = 0.8, xend = 11.8, yend = 0.8), size = 1, color = "blue") +
  geom_segment(aes(x = 4.8, y = 0.2, xend = 11.8, yend = 0.2), size = 1, color = "blue") +
  annotate("text", x = 4.9, y = 0.9, label = expression(A[1]), hjust = 0, size = 6, color = "black") +
  annotate("text", x = 4.9, y = 0.1, label = expression(A[2]), hjust = 0, size = 6, color = "black") +
  annotate("text", x = 0.9, y = 0.75, label = "T0 after A", fontface = "bold", size = 5, color = 'purple') +
  theme_void()
p
```
:::
:::

## [RWD: Time zero problem]{style="color:#FF6666;"}

::: {.layout-ncol="2"}
-   **HR 0.85 (0.82-0.87)**

![](img/nejmprev.png){width="45%"} ![](img/nejmdesign.png){width="45%"}
:::

## [RCT]{style="color:#FF6666;"}

::: {.layout-ncol="1"}
\-**HR 1.00(0.93-1.08)**

![](img/meta.png)
:::

## [RWD: Time zero problem]{style="color:#FF6666;"}

::: columns
::: {.column width="40%"}
-   **Immortal time bias**
-   E: Menopause
-   T0: Start Follow-up
-   A: HRT assignment
:::

::: {.column width="60%"}
```{r, echo=FALSE}
library(ggplot2)
library(grid)

p <- ggplot() + 
  geom_segment(aes(x = 0, y = 0.5, xend = 4.5, yend = 0.5), size = 1, color = "black") +
  geom_rect(aes(xmin = 4.5, xmax = 5.5, ymin = 0.45, ymax = 0.55), color = "black", fill = 'gray', alpha = 0.5) +
  annotate("text", x = 5, y = 0.60, label = "Washout period w/o\nstudy drug use", size = 3, hjust = 0.5) +
  geom_point(aes(x = 3.5, y = 0.5), shape = 15, size = 3, color = "red") +
  annotate("text", x = 3.5, y = 0.65, label = "T0", color = "blue", size = 5) +
  annotate("text", x = 4.9, y = 0.85, label = "A", color = "red", size = 6) +
  annotate("text", x = 3.5, y = 0.70, label = "E", color = "black", size = 5) +
  geom_segment(aes(x = 3.5, y = 0.5, xend = 4.8, yend = 0.8), size = 1, color = "blue") +  
  geom_segment(aes(x = 3.5, y = 0.5, xend = 4.8, yend = 0.2), size = 1, color = "blue") + 
  geom_segment(aes(x = 4.8, y = 0.8, xend = 11.8, yend = 0.8), size = 1, color = "red") +
  geom_segment(aes(x = 4.8, y = 0.2, xend = 11.8, yend = 0.2), size = 1, color = "red") +
  annotate("text", x = 4.9, y = 0.9, label = expression(A[1]), hjust = 0, size = 6, color = "black") +
  annotate("text", x = 4.9, y = 0.1, label = expression(A[2]), hjust = 0, size = 6, color = "black") +
  annotate("text", x = 0.9, y = 0.75, label = "A after T0", fontface = "bold", size = 5, color = 'purple') +
  theme_void()
p
```
:::
:::

## [RWD: Time zero problem]{style="color:#FF6666;"}

::: {.layout-ncol="1"}
-   **RR 0.61 (0.52-0.71)** <img src="img/hrt.png"/>
-   *“Women were asked about use and duration of hormone therapy after menopause.(Updated biennially)”*
:::

## [RCT]{style="color:#FF6666;"}

::: {.layout-ncol="1"}
-   **HR 1.23 (0.99-1.53)** <img src="img/hrtnejm.png"/>
:::

# [Target Trial Emulation]{style="color:navy;"}

## [Back to Question]{style="color:#FF6666;"}

```{r}
library(DiagrammeR)
grViz("
  digraph {
    rankdir=LR
    node [shape = plaintext, fontcolor=navy, fontname=\"Arial\"]
    edge [color=red, penwidth=0.5]
    A -> Y
  }
")
```

## [How about?]{style="color:#FF6666;"}

<br> - Emulate RCT to avoid bias!

## [Key components of protocol]{style="color:#FF6666;"}

-   Treatment strategies
-   Eligibility criteria
-   Outcomes of interest
-   Start and End of F/U
-   Casual contrast
-   Data Analysis plan

## [Key components of protocol]{style="color:#FF6666;"}

-   **Treatment strategies**
-   Eligibility criteria
-   Outcomes of interest
-   Start and End of F/U
-   Casual contrast
-   Data Analysis plan

## [TTE: Treatment strategies]{style="color:#FF6666;"}

::: {.container .text-center}
<img src="img/ideal.png" style="width:55%; display:block; margin: 0 auto;"/>

-   **E:** eGFR \< 30
-   **Group A:** eGFR 10-14
-   **Group B:** eGFR 5-7
-   Observational studies investigating this causal question showed a **strong survival advantage for late dialysis start**
:::

## [TTE: Treatment strategies]{style="color:#FF6666;"}

::: incremental
-   Lets consider Observational trial
-   **Can we assign Individual to Unique strategies?**
-   Ex) Individual with *eGFR 16* at FU 1month
-   Strategy A or B?
:::

# [Clone Censor Weight method]{style="color:navy;"}

## [TTE: Clone Censor Weight method]{style="color:#FF6666;"}

::: incremental
-   Why not All?
-   Double allocation: prevents bias of random assignment
-   Just Clone and censor <img src="img/ccw.png" height="400px" width="auto"/>
:::

## [TTE: Clone Censor Weight method]{style="color:#FF6666;"}

```{r, echo=FALSE}
library(flextable)
data <- data.frame(
  Specific_Analysis = c("Randomized IDEAL trial", "Target trial emulation analysis", 
                        "Common but biased analysis 1", "Common but biased analysis 2"),
  Correct_Study_Design = c("Yes", "Yes", "No", "No"),
  Biases_Introduced = c("—", "—", "Selection bias (depletion of susceptibles), lead time bias", 
                        "Immortal time bias"),
  Confounding_Adjustment_Necessary = c("No", "Yes", "Yes", "Yes"),
  Hazard_Ratio_CI = c("1.04 (0.83 to 1.30)", "0.96 (0.94 to 0.99)", 
                      "1.58 (1.19 to 1.78)", "1.46 (1.19 to 1.78)")
)
colnames(data) <- gsub("_", " ", colnames(data))  
ft <- flextable(data) %>%
  set_header_labels(`Specific Analysis` = "Specific Analysis",
                    `Correct Study Design` = "Correct Study Design",
                    `Biases Introduced` = "Biases Introduced",
                    `Confounding Adjustment Necessary` = "Confounding Adjustment Necessary",
                    `Hazard Ratio CI` = "Hazard Ratio (95% CI)") %>%
  bold(i = ~ grepl("Selection bias", `Biases Introduced`) | grepl("Immortal time bias", `Biases Introduced`), 
       j = "Biases Introduced") %>%
  bold(i = ~ grepl("1.58", `Hazard Ratio CI`) | grepl("1.46", `Hazard Ratio CI`), 
       j = "Hazard Ratio CI") %>%
  autofit()
ft
```

## [Is there Immediate Assignment?]{style="color:#FF6666;"}

::: incremental
-   Do we recieve surgery at the moment diagnosed?
-   Grace period!
-   *Real world: investigators need to define grace period after time zero during which initiation is still considered to be immediate*
:::

## [Is there Immediate Assignment?]{style="color:#FF6666;"}

::: incremental
-   If 6 months: surgery at 1 month, 3month <br> -\> Can be on Tx group!
-   Redefinition of intervention(Ex. Control vs Surgery in 6M)
-   Death/FU loss before 6 month?
:::

## [TTE: Clone censor weight with grace period]{style="color:#FF6666;"}

<img src="img/lancethead.png"/>

## [TTE: Clone censor weight with grace period]{style="color:#FF6666;"}

<img src="img/ccw2.png"/>

## [TTE: Clone censor weight with grace period]{style="color:#FF6666;"}

<img src="img/ccw3.png"/>

## [TTE: Clone censor weight with grace period]{style="color:#FF6666;"}

<img src="img/ccw4.png"/>

## [TTE: Censor Induces Selection Bias!]{style="color:#FF6666;"}

<img src="img/wt.png"/>

## [TTE: Censor Induces Selection Bias!]{style="color:#FF6666;"}

<img src="img/censorgraph.png"/>

## [TTE: Censor Induces Selection Bias!]{style="color:#FF6666;"}

<img src="img/censorgraph2.png"/>

## [ITT: is it possible?]{style="color:#FF6666;"}

-   Closest Analog: Comparison of initiation strategy
-   If RCT?: All people not taking treatment at baseline <br> -\> *goes to same group*
-   If initiation occurs shortly after assignment to treatment <br> -\> *observation analogue roughly preserves key feature*
-   Per-protocol effect of Initiator vs non-Initiator!

## [TTE: Clone censor weight]{style="color:#FF6666;"}

-   Grace Period
-   Start Tx based on Biomarker
-   Tx duration comparison
-   How about A vs B?

# [Active Comparator New User Design]{style="color:navy;"}

## [TTE:ACNU]{style="color:#FF6666;"}

-   How about A vs B?

## [TTE:ACNU]{style="color:#FF6666;"}

<img src="img/acnu.png"/>

## [TTE:ACNU]{style="color:#FF6666;"}

-   What about Preventive measure?

# [Multiple sequential trial]{style="color:navy;"}

## [TTE: Multiple sequential trial]{style="color:#FF6666;"}

::: incremental
-   What if individual meets eligibility criteria multiple times?
-   Randomly chose eligible time
-   Every eligible time: Multiple sequential trial
:::

## [TTE: Multiple sequential trial]{style="color:#FF6666;"}

<img src="img/multiple.png"/>

## [TTE: Multiple sequential trial]{style="color:#FF6666;"}

::: incremental
-   ITT: initiator vs non-initiator
-   PP: continuous user vs never user
-   As-treated: N year user vs non user
:::

## [TTE: Multiple sequential trial]{style="color:#FF6666;"}

-   Unmeasured Confounding
-   Ex) One could recieve Tx when in Danger!
-   Ex) What if it takes DM drugs to have effect 3M?

## [TTE: Multiple sequential trial]{style="color:#FF6666;"}

::: incremental
-   HRT after Menopause
-   What if we exclude early followup?
-   HR deviation(time-varying)
-   Selection Bias!
:::

## [Common observational study]{style="color:#FF6666;"}

-   *Current vs never(non) user analysis*
-   Hadrd to adjust for measured confounders <br> that are affected by prior treatment
-   Ex) LDL in Statin\~CHD

## [Common observational study]{style="color:#FF6666;"}

-   *Current vs never(non) user analysis*
-   A: Statin Assign
-   L: LDL
-   D: CHD
-   U: Poor diet 

<img src="img/dag.png"/>

## [TTE: Multiple sequential trial]{style="color:#FF6666;"}

-   *Current vs never(non) user analysis*
-   Unmeasured Confounding vs Selection Bias

## [TTE: Multiple sequential trial]{style="color:#FF6666;"}

<img src="img/adhr.png"/>

## [TTE: Multiple sequential trial]{style="color:#FF6666;"}
-   Do people stick to single therapy?
-   What about dynamic Strategy?
-   Real world: Time-varying treatment

# [G-Methods]{style="color:navy;"}

## [G-Methods]{style="color:#FF6666;"}

<img src="img/dag2.png"/>

## [G-Methods]{style="color:#FF6666;"}
-   Methods that can handle treatment confounder feedback
-   G-computation algorithm formula
-   IP weighting
-   Doubly-robust methods
-   G-estimation

## [G-Formula]{style="color:#FF6666;"}
<img src="img/tree.png"/>

## [G-Formula: Assumptions]{style="color:#FF6666;"}
-   Conditional exchangeability
-   Positivity
-   Consistency: Observed outcome = potential outcome
-   No interference: individual i의 outcome과 j의 tx는 독립
-   High demensional data->Parametric Approach!

## [G-Formula: Time-varying treatment]{style="color:#FF6666;"}
<img src="img/ice.png"/>

## [G-Formula: Time-varying treatment]{style="color:#FF6666;"}
-   Main Question:
-   What if no ICE?
-   ICE probability should not be 1
-   Ex) L1이 특정 값일 때 A1이 결정되는 경우!

## [G-Formula: Time-varying treatment]{style="color:#FF6666;"}
-   Main Question:
-   What if no ICE?
-   ICE probability should not be 1
-   Ex) L1이 특정 값일 때 A1이 결정되는 경우!

## [G-Formula: Time-varying treatment]{style="color:#FF6666;"}
<img src="img/gfrom1.png"/>
<img src="img/gfrom2.png"/>

## [G-Formula: Time-varying treatment]{style="color:#FF6666;"}
<img src="img/gfrom3.png"/>

## [G-Formula: What if no ICE?]{style="color:#FF6666;"}
-   a1 is fixed to 0!
-   No need to consider how ICE effects Y

## [G-Formula: What if no ICE?]{style="color:#FF6666;"}
<img src="img/noice.png"/>


## [G-Formula: Time-varying treatment]{style="color:#FF6666;"}
<img src="img/gfrom4.png"/>

## [G-Formula: Time-varying treatment]{style="color:#FF6666;"}
<img src="img/gfrom5.png"/>

## [G-Formula: Multiple ICE]{style="color:#FF6666;"}
<img src="img/mulice.png"/>






## [G-Formula: Double robustly estimation]{style="color:#FF6666;"}
-   Combine IP weight and ICE g formula



## [G-Formula: Double robustly estimation]{style="color:#FF6666;"}
-   Step by time K
-   Step1: Fit logistic regression to calculate Lk->IP weight
-   Step2: 


## [G-Formula: Dynamic strategy]{style="color:#FF6666;"}


## [G-Formula: Missing data]{style="color:#FF6666;"}
-   TBC

## [G-Formula: Censoring]{style="color:#FF6666;"}
-   TBC
